Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

World Health Organization, Solid Tumors, Cancer Management +17

Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen

David W. M. Leung, George Cachianes, Wun-Jing Kuang et al. · Science · 1989 · 5K citations

Inflammation, Secreted Angiogenic Mitogen, Human Vegf +13

Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid

Donald R. Senger, Stephen J. Galli, Ann M. Dvořàk et al. · Science · 1983 · 4K citations

Pathology, Tumor Cells Secrete, Cellular Physiology +18

Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF

Pamela J. Keck, Scott D. Hauser, Gwen G. Krivi et al. · Science · 1989 · 2.1K citations

Immunology, Cellular Physiology, Tumor Biology +19

Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

Robert A. Burger, Michael W. Sill, Bradley J. Monk et al. · Journal of Clinical Oncology · 2007 · 878 citations · Full text